Capillary rarefaction from the kidney point of view

Area of Science:

• Nephrology
• Vascular Biology
• Cardiovascular Research

Background:

• Capillary rarefaction, defined as reduced vascular density, is implicated in kidney disease progression.
• It is associated with kidney hypoxia, impaired hemodynamics, and the development of hypertension.
• Understanding its mechanisms is crucial for managing chronic kidney disease (CKD).

Purpose of the Study:

• To review noninvasive clinical monitoring tools for capillary rarefaction.
• To summarize the contribution of capillary rarefaction to CKD and hypertension.
• To discuss mechanisms and potential therapeutic strategies for capillary rarefaction.

Main Methods:

• Literature review of studies on capillary rarefaction in kidney disease.
• Analysis of mechanisms including inflammation, growth factor deficiency, and cellular crosstalk.
• Evaluation of therapeutic targets such as vitamin D receptor activators and stem cell therapy.

Main Results:

• Capillary rarefaction is a key factor in CKD and hypertension development.
• Multiple pathways contribute to capillary rarefaction, including TGF-β1 and vitamin D deficiency.
• Noninvasive monitoring tools are available for clinical assessment.

Conclusions:

• Capillary rarefaction significantly impacts CKD and hypertension.
• Targeting mechanisms like inflammation and growth factor pathways offers therapeutic potential.
• Future strategies may involve vitamin D receptor activators, sirtuin 1 activators, and stem cell therapy.